Invention Grant
![Pyrazolo[1,5-A]pyrimidine-carbonyl-piperazine derivatives](/docs/US/2012-01-10/US08093249B2/abs.jpg.600x600.jpg)
- Patent Title: Pyrazolo[1,5-A]pyrimidine-carbonyl-piperazine derivatives
- Patent Title (中): 吡唑并[1,5-A]嘧啶 - 羰基 - 哌嗪衍生物
-
Application No.: US12503135Application Date: 2009-07-15
-
Publication No.: US08093249B2Publication Date: 2012-01-10
- Inventor: Jag Paul Heer , David Norton , Simon E Ward
- Applicant: Jag Paul Heer , David Norton , Simon E Ward
- Applicant Address: GB London
- Assignee: Convergence Pharmaceuticals Limited
- Current Assignee: Convergence Pharmaceuticals Limited
- Current Assignee Address: GB London
- Agency: Womble Carlyle Sandridge & Rice, LLP
- Priority: GB0813144.3 20080717
- Main IPC: A61K31/497
- IPC: A61K31/497 ; C07D487/00
![Pyrazolo[1,5-A]pyrimidine-carbonyl-piperazine derivatives](/abs-image/US/2012/01/10/US08093249B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to novel piperazine derivatives; to processes for their preparation; to pharmaceutical compositions containing the derivatives; and to the use of the derivatives in therapy to treat diseases for which blocking the Cav2.2 calcium channels is beneficial.
Public/Granted literature
- US20100016330A1 Novel Derivatives Public/Granted day:2010-01-21
Information query
IPC分类:
